Theresa Heggie, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 70,000 shares at $8.51 ($596K) on 2025-08-13, disclosed to the SEC on 2025-08-15.
Open-market sale of $596k BCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BCRX | BUY | 2019-11-18 | $7K | — | Filing → |